American based Avantor Performance Materials will acquire polish performance materials supplier POCH S.A.
American based Avantor Performance Materials will acquire Polish performance materials supplier POCH S.A.
“The transaction is part of Avantor’s strategy to strengthen its presence in the global market by growing both organically and through acquisition, expanding into new markets and geographies,” said Avantor President and Chief Executive Officer Jean-Marc Gilson. “POCH fits this strategy because of its established and expansive manufacturing presence and distribution channel in Poland and Eastern Europe.”
Avantor Performance Materials, formerly Mallinckrodt Baker, manufactures and markets high-performance chemistries and materials around the world. Avantor products are used in a wide range of industries including biotechnology and pharmaceutical production; electronics and photovoltaic manufacturing; as well as in research, academic and quality control laboratories.
“This acquisition will allow for synergies in market and production know-how and enrichment of the combined product portfolio, significantly increasing the level of expertise dedicated to various industry sectors,” said POCH chief executive officer Jarosław Bieszczad. “It will also enhance the competitive standing of POCH, enabling us to offer the high-quality Avantor product lines to our customers, while also giving us new markets for our products through the global Avantor organization.”
Based in Poland, POCH manufactures products designed for use in classic and instrumental analysis, filtration and microbiology. The company also manufactures solvents for liquid and gas chromatography and spectroscopy as well as anhydrous solvents, and sells laboratory equipment and laboratory glass. Its markets include pharmaceuticals; food and feed; chemical and petrochemical; environmental protection and research and analytical chemistry.
For more information visit www.avantormaterials.com or www.english.poch.com.pl
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.